Navigation Links
Heart disease in women being under-treated

A new study involving 2,763 post menopausal women with heart disease has shown that doctors are under-using aspirin, beta blockers and cholesterol lowering drugs to treat these women even though the medications have been shown to prevent further heart attacks or other heart trouble. Though this study did not look at how often these drugs were offered to men, previous// studies have shown that men and women alike are under-treated for heart disease, and women are treated even less aggressively than men. Dr. Michael Shlipak of the University of California, co-author of the study said that these findings could have many reasons including a lingering myth that heart disease is primarily a man's disease, doctors not using effective prevention methods and also the fear of side effects of preventive drugs in both doctors and patients.

In the study of the 2,763 women, all had suffered heart attacks or chest pain caused by blocked arteries, or had undergone bypass surgery or angioplasty. It was found by the researchers that only one third of these women who should have been taking beta blockers, were taking it and only half the women who qualified for cholesterol-lowering drugs took them. They said that even aspirin, which all of the survivors should have been taking, was taken only by 80 percent.

Dr. Naveed Malik, a cardiologist at the Ochsner Clinic Foundation in New Orleans, who was not connected with the study, said that a woman complaining of chest pain is often detected with heart burn, while similar symptoms in men might prompt doctors to think about coronary artery disease first. In an accompanying editorial, Drs. Andrew Miller and Suzanne Oparil of the University of Alabama added that the research highlighted the terrible discrepancy between what doctors knew about heart disease and how women with the disease were being treated. In conclusion, the article which was published in the Annals of Internal Medicine, said that this study should prove to be a wake-up call to physicians who need to more aggressively use appropriate drugs like aspirin, beta blockers and ACE inhibitors in women with heart disease.


'"/>




Related medicine news :

1. One in Three Heart Attack Patients Have No Chest Pains
2. Epileptic Seizures Can Be Due to Heart Problem
3. Bypass Heart Surgery Performed Without General Anesthesia
4. New CPR Guidelines issued by Heart Association
5. White Cells Count Can Predict Heart Attack Death Risk
6. Vitamins-The answer to Heart Disease?
7. Fight Heart disease and Pain with Meditation
8. Heart disease in the newborn is related to maternal malnutrition
9. New drug to treat Heart Attack and damaged tissue
10. Heart disease threat starts early in life for Diabetics
11. Mechanical Heart
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/28/2017)... Linda, Ca (PRWEB) , ... April 28, 2017 ... ... with cardiac or hERG liability could substantially improve drug safety and minimize the ... be provided for validating ion channel inhibition using cell lines and for cardiac ...
(Date:4/28/2017)... FL (PRWEB) , ... April 28, 2017 , ... ... Florida are conducting a pilot study of ActiGraph’s CentrePoint Data Hub ... is a leading provider of clinical-grade wearable activity and sleep monitoring solutions for ...
(Date:4/28/2017)... ... , ... NuevaCare, a leading home care agency based in San Mateo, California, ... proud to announce information upgrades to its blog in the form of WordPress tags. ... such as home care (generally) as well as senior care and home care agency ...
(Date:4/27/2017)... ... April 27, 2017 , ... ... respiratory hospital, based in Denver, Colorado, announced an agreement to create the Jane ... continuing support of the Jane and Leonard Korman Family Foundation. The collaboration leverages ...
(Date:4/27/2017)... (PRWEB) , ... April 27, 2017 , ... ... her husband Dan Gasby the 2017 Public Leadership in Neurology Award (PLINA). The ... retired professional athlete Tedy Bruschi, Vice President Walter Mondale, actor Michael J. Fox ...
Breaking Medicine News(10 mins):
(Date:4/19/2017)... NEW YORK , April 19, 2017 /PRNewswire/ ... This report on the prostate cancer ... of the global market. Increasing prevalence of prostate ... as innovation in the development of new drugs ... hormone-refractory prostate cancer drug due to lesser side ...
(Date:4/19/2017)... PUNE, India , April 19, 2017 ... Type and Application, Forecast to 2022 report has covered and ... provides statistics and information on market size, shares and growth ... with major drivers, challenges and opportunities in the global market. ... Browse 152 Tables and ...
(Date:4/19/2017)... , April 19, 2017 ... stimulate an immune response in pets such as ... products are of various types such as Attenuated ... Toxoid Vaccines, DNA Vaccines and Recombinant Vaccines. Attenuated ... as virus or bacteria, which have been weakend ...
Breaking Medicine Technology: